Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 27916398

Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2017 Jan
First author
Passamonti F

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2017 Jan;18(1):9-11. doi: 10.1016/S1470-2045(16)30591-5.
    note
    Source null
    related pmid
    27916397
    relationship
    Comment in

Authors and identifiers

  1. name
    Passamonti F
    type
    Author
  2. name
    Griesshammer M
    type
    Author
  3. name
    Palandri F
    type
    Author
  4. name
    Egyed M
    type
    Author
  5. name
    Benevolo G
    type
    Author
  6. name
    Devos T
    type
    Author
  7. name
    Callum J
    type
    Author
  8. name
    Vannucchi AM
    type
    Author
  9. name
    Sivgin S
    type
    Author
  10. name
    Bensasson C
    type
    Author
  11. name
    Khan M
    type
    Author
  12. name
    Mounedji N
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Passamonti F
    type
    Author
  2. name
    Griesshammer M
    type
    Author
  3. name
    Palandri F
    type
    Author
  4. name
    Egyed M
    type
    Author
  5. name
    Benevolo G
    type
    Author
  6. name
    Devos T
    type
    Author
  7. name
    Callum J
    type
    Author
  8. name
    Vannucchi AM
    type
    Author
  9. name
    Sivgin S
    type
    Author
  10. name
    Bensasson C
    type
    Author
  11. name
    Khan M
    type
    Author
  12. name
    Mounedji N
    type
    Author
bibliography ids
  1. nci-bib-72ee015e42b49015717deadb
book metadata
content sha256
70fcc3c9a862dbad1218230b7a740ec3c1c60512ebb29163b5f9bf346e8c00d5
document type
citation
dois
  1. 10.1016/S1470-2045(16)30558-7
electronic publication date
display
2016 Dec 2
precision
day
year
2016
evidence scope
bibliographic_metadata_only
id
pubmed:27916398
immutable id
pubmed:27916398@70fcc3c9a862dbad1218230b7a740ec3c1c60512ebb29163b5f9bf346e8c00d5
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
1
name
The Lancet. Oncology
nlm unique id
100957246
pages
88-99
volume
18
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2017 Jan;18(1):9-11. doi: 10.1016/S1470-2045(16)30591-5.
    note
    Source null
    related pmid
    27916397
    relationship
    Comment in
outcomes validated
false
pmid
27916398
provenance
batch id
7a1288ac8bb5f9826304
provider
NCBI PubMed ESummary
record sha256
d7d86253a550b2f953fb51d05dc86c245a9785e1f4462c9bc7144f9ae8bf2be9
response sha256
0e879bec8c19d1cfda5629dca8745b04155d18cf54361825d4c070aebad2984d
retrieved at
2026-09-09T23:47:23.138359+00:00
publication date
display
2017 Jan
precision
month
year
2017
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/27916398/
title
Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study.

Preserved source evidence · Not medical advice